Clinical Trial Update: A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of a Phase I/II clinical trial evaluating PepCan in head and neck cancer, with results posted on 2025-10-08.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• PepCan

Snippet

Sponsor: University of Arkansas | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-08